Is BDNF approved as a medicine, and where?

The regulatory review of BDNF is incomplete. See the article's sources for product- and country-specific findings and remaining uncertainties. Review status means neither worldwide approval nor worldwide absence of approval.

What is BDNF studied for?

BDNF is most often discussed in the context of cognition, mood & sleep. Being studied for an area does not mean it is proven or approved for it.

Does BDNF have human clinical trials?

The evidence review of BDNF is in progress. The article's study appraisal identifies any human studies located and their limitations. An ongoing review does not itself mean that human studies are absent.

Index by category›

Nootropic & Neuropeptides

BDNF

1 min read · Updated September 14, 2026 · 2 references

Curated by PeptideInfo Wikilast reviewed September 14, 2026how we verify

Explored forCognition, mood & sleep

BDNF is an endogenous neurotrophic protein involved in neuronal survival and synaptic plasticity.

Body & signals →

No receptor relationship mapped here yet. This does not mean the molecule has no biological effects.

Review pending

Contents3

Section 1 of 3What is it?

What is it?

BDNF is an endogenous neurotrophic protein involved in neuronal survival and synaptic plasticity. Mature BDNF and its precursor proBDNF are distinct forms; the receptor context matters. TrkB, encoded by NTRK2, is a major receptor for mature BDNF. C01 (opens in a new tab)

Section 2 of 3What was studied?

What was studied?

A randomized trial in 1135 people with ALS compared recombinant methionyl human BDNF with placebo over 9 months. It did not demonstrate benefit on the primary endpoints. Apparent benefits in selected subgroups came from post hoc analyses and require confirmation; they do not turn the overall trial into a positive result. C02 (opens in a new tab)

Section 3 of 3What does the result mean?

What does the result mean?

An intervention reported to increase BDNF is not itself BDNF. To understand such a claim, ask which form was measured, in which tissue, and whether a functional outcome changed. A change in expression alone does not establish improved memory. This distinction helps when reading about Semax and 9-ME-BC. C03 (opens in a new tab)

References2

References

1.
UniProt P23560 — human BDNF source
2.
BDNF Study Group, 1999 — controlled recombinant BDNF trial in ALS source

Frequently asked questions4

Frequently asked questions

What is BDNF?: BDNF is an endogenous neurotrophic protein involved in neuronal survival and synaptic plasticity.
Is BDNF approved as a medicine, and where?: The regulatory review of BDNF is incomplete. See the article's sources for product- and country-specific findings and remaining uncertainties. Review status means neither worldwide approval nor worldwide absence of approval.
What is BDNF studied for?: BDNF is most often discussed in the context of cognition, mood & sleep. Being studied for an area does not mean it is proven or approved for it.
Does BDNF have human clinical trials?: The evidence review of BDNF is in progress. The article's study appraisal identifies any human studies located and their limitations. An ongoing review does not itself mean that human studies are absent.

Educational disclaimer. This article summarizes published research for informational purposes and is not medical advice. The editorial review of BDNF is incomplete. Source-supported findings and remaining uncertainties are stated in the article; review status does not certify approval, safety or suitability for use. Consult a qualified healthcare professional before making health decisions.